Omega-3

Results showed that both doses of krill oil significantly reduced TEWL, and increased hydration as well as elasticity compared to placebo.

SourceOne Global Partners has announced a partnership with Qualitas Health Inc., (dba iwi life) to introduce the company’s trademarked AlmegaPL microalgae omega-3 ingredient to the global marketplace.

The Canadian companies have joined forces to create more cost-effective and bioavailable fortification of plant-based omega-3s.

A recently published study found that Ahiflower oil from the seeds of Buglossoides arvensis may improve plasma eicosapentaenoic acid (EPA) levels.

A recent animal study found that lysophosphatidylcholine (LPC)-bound omega-3 long-chain polyunsaturated fatty acids (LCPUFAs), marketed as Lysoveta by Aker BioMarine, protected against neonatal hypoxic-ischemic (HI) brain injury in mice.

The study was conducted at 20 research centers in the United States by Aker BioMarine and the Lupus Clinical Investigators Network with oversight by Lupus Therapeutics, the clinical research affiliate of the Lupus Research Alliance.

Researchers reviewed 11 studies and found that there was no difference in the incidence of bleeding events between patients receiving omega-3 PUFAs and those not receiving them. High dose EPA consumption was associated with an elevated but modest risk.

According to the paper’s author, Stephanie Venn-Watson, DVM, MPH, deficiency in pentadecanoic acid of ≤0.2% total circulating fatty acids increases the risk of ferroptosis, which a type of cell death cause by the peroxidation of fragile fatty acids in cell membranes that combines with iron thus increasing reactive oxygen species, and disabling mitochondria.

The $75 million facility expansion allows the company to double its output of the triglyceride form of marine omega-3s EPA and DHA and certified vegan EPA & DHA algal oils.

The researchers concluded that fish oil supplementation by healthy people may actually put them at risk of developing atrial fibrillation and stroke, while offering a benefit to those diagnosed with cardiovascular disease by reducing their risk of experiencing major adverse cardiovascular events.

The article commissioned by The Global Organization for EPA and DHA Omega-3s (GOED) reviewed the state of omega-3 fatty acid testing, highlighting the value of testing and the commercially available options for diagnostic testing.

The blend of long-chain polyunsaturated fatty acids and long-chain monounsaturated fatty acids combines the heart and brain health benefits of omegas-3s with the skin and metabolic health benefits of omegas 9 and 11.

At-home testing and wearable tech will put supplements to the test as consumers measure and track their cardiovascular, liver, and blood sugar health.

GC Rieber VivoMega has announced that its three omega-3 facilities are running on 100% renewable energy after having implemented an electric steam boiler to power its marine and microalgae omega-3 operations.

At this year’s Natural Products Expo West, two brands have launched their own versions of algae DHA ingredients; FrieslandCampina and Aker BioMarine. Each brand showcased a different approach to the ingredient.

Nutritional Outlook talks to Matts Johansen, CEO of Aker BioMarine, about the company's new algae DHA ingredient, FloraMarine.

A look at marine plants and how to sustainably harvest and process them.

The company states that the oil delivers 60% DHA.

In the study, supplementation alone did not have a significant impact on cardiovascular outcomes in patients who've recovered from mycocardial infarction. However, subjects taking omega-3s that had a 5% increase in omega-3 index did see better health outcomes than those who did not.

FrieslandCampina Ingredients has announced the launch of two algae-based DHA ingredients: Biotis DHA FlexP 15 and Biotis DHA FlexP 20.

GOED announces new chair, vice-chair, and secretary.

Aker BioMarine has announced an exclusive partnership with Brazilian distributor Kilyos Nutrition.

Bioriginal Food & Science Corp. has announced the acquisition of POS Biosciences Corp. (Saskatoon, Saskatchewan, Canada) from Canopy Growth Corp.

A recent pooled analysis of 29 cohorts made up of 183,291 participants found a link between omega-3 blood levels (Omega-3 Index) and stroke risk.

Nutritional Outlook’s Editorial Advisory Board members highlight potential challenges for the nutraceutical, natural product, and health and wellness industries in 2024.

OmegaQuant has announced the receipt of a small business innovation research (SBIR) grant to develop a test that identifies fatty acid patterns to predict dementia risk as an early screening tool.

Formulating children’s supplements requires balancing the tried-and-true and innovation.

Softgel Co. provides contract manufacturing services for softgels as well as bottling, packaging, and labeling.

Omega-3 suppliers rolled out their latest advancements, spanning algae innovations and better sensory measurements.

Is the omega-3 market big enough for all types of ingredient sources?